The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients
Abstract
Objective (1) To determine chronic illness costs for large cohort of primary care patients, (2) to develop prospective model predicting total costs over one year, using demographic and clinical information including widely used comorbidity index.Study design and setting Data including diagnostic, medication, and resource utilization were obtained for 5,861 patients from practice-based computer system over a 1-year period beginning December 1, 1993, for retrospective analysis. Hospital cost data were obtained from hospital cost accounting system.Results Average annual per patient cost was $2,655. Older patients and those with Medicare or Medicaid had higher costs. Hospital costs were $1,558, accounting for 58.7% of total costs. In the predictive model, individuals with higher comorbidity incurred exponentially higher annual costs, from $4,317 with comorbidity score of two, to $5,986 with score of three, to $13,326 with scores greater than seven. To use an adapted comorbidity index to predict total yearly costs, four conditions should be added to the index: hypertension, depression, and use of warfarin with a weight of one, skin ulcers/cellulitis, a weight of two.Conclusion The adapted comorbidity index can be used to predict resource utilization. Predictive models may help to identify targets for reducing high costs, by prospectively identifying those at high risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Self-citationAdapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the Elderly
Wolff, J. L., Starfield, B. H., & Anderson, G. F. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.20.2269 · Cited by 2,237
Reimbursing Health Plans and Health Providers: Efficiency in Production versus Selection
Newhouse, J. P. (1996) · RePEc: Research Papers in Economics · Cited by 565
Health care costs associated with depressive and anxiety disorders in primary care
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.352 · Cited by 555
Increased Medical Costs of a Population-Based Sample of Depressed Elderly Patients
Katon, W. J., Lin, E. H. B., Russo, J. E., & Unützer, J. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.897 · Cited by 500
The Growing Burden of Chronic Disease in America
Anderson, G. F., & Horvath, J. (2004) · Public Health Reports · doi:10.1016/j.phr.2004.04.005 · Cited by 494
Potentially avoidable hospitalizations: inequalities in rates between US socioeconomic groups.
Pappas, G., Hadden, W. C., Kozak, L. J., & Fisher, G. F. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.5.811 · Cited by 399
Cited by
Sorted by citations
Items 101–200 of 891
Geryk, L. L., Carpenter, D. M., Blalock, S. J., DeVellis, R. F., & Jordan, J. M. (2015) · PubMed · Cited by 50
Ajmera, M. R., Boscoe, A. N., Mauskopf, J., Candrilli, S. D., & Levy, M. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.11.022 · Cited by 50
“The CCI is a measure of patients' overall comorbidity burden and includes 20 categories of comorbidities, as defined by ICD-9-CM diagnosis and procedure codes, with associated weights corresponding to the severity of the comorbid condition of interest [20].”
Hong, C. S., Atlas, S. J., Ashburner, J. M., Chang, Y., He, W. W., Ferris, T. G. G., & Grant, R. W. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3357-8 · Cited by 50
Lavigne, J., Bruyère, F., Bernard, L., Combescure, C., Ronco, E., Lanotte, P., Coloby, P. J., Thibault, M., Cariou, G., Desplaces, N., et al. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000247 · Cited by 49
Ohno, S., Chen, Y., Sakamaki, H., Matsumaru, N., Yoshino, M., & Tsukamoto, K. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.1877149 · Cited by 49
Evaluation of Health Care Costs and Utilization Patterns for Patients With Gout
Park, H., Rascati, K. L., Prasla, K., & Mcbayne, T. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.01.020 · Cited by 48
Shah, N., Bhor, M., Xie, L., Arcona, S., Halloway, R., Paulose, J., & Yüce, H. (2019) · Journal of health economics and outcomes research · doi:10.36469/9667 · Cited by 48
Sherwood, N. E., Crain, A. L., Martinson, B. C., Anderson, C. P., Hayes, M. G., Anderson, J. D., Senso, M. M., & Jeffery, R. W. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2012.12.014 · Cited by 50
“The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients.”
MethodInfluentialBoulware, L. E., Ephraim, P. L., Ameling, J. M., Lewis-Boyér, L., Rabb, H., Greer, R. C., Crews, D. C., Jaar, B. G., Auguste, P., Purnell, T. S., et al. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0901-x · Cited by 47
“We also assessed participants’ comorbidity (using the Charlson Comorbidity Index [26] modified for end stage renal disease) and their presence of depression (using the validated PHQ-8 [27]).”
MethodNagar, S. P., Mytelka, D. S., Candrilli, S. D., Dyachkova, Y., Lorenzo, M., Kasper, B., Lopez-Martin, J. A., & Kaye, J. A. (2018) · Sarcoma · doi:10.1155/2018/5467057 · Cited by 47
Shah, A., Xie, L., Kariburyo, F., Zhang, Q., & Gore, M. R. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0786-x · Cited by 47
Bermingham, M., Hayden, J. C., Dawkins, I. R., Miwa, S., Gibson, D., McDonald, K., & Ledwidge, M. T. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.07.007 · Cited by 46
Black, C. M., Fillit, H. M., Xie, L., Hu, X., Kariburyo, M. F., Ambegaonkar, B. M., Başer, O., Yüce, H., & Khandker, R. K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170518 · Cited by 46
“Studies on hospital data have suggested that early and timely detection of AD can be cost-saving [6, 10, 22].”
Asche, C. V., Kim, J., Kulkarni, A. S., Chakravarti, P., & Andersson, K. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10436.x · Cited by 45
Tsang, C., Bottle, A., Majeed, A., & Aylin, P. P. (2013) · British Journal of General Practice · doi:10.3399/bjgp13x670660 · Cited by 47
Are generic and brand-name statins clinically equivalent? Evidence from a real data-base
Corrao, G., Soranna, D., Arfè, A., Casula, M., Tragni, E., Merlino, L. G., Mancia, G., & Catapano, A. L. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.08.002 · Cited by 45
“Additional information included 1) gender and age at index date; 2) co-treatment with antihypertensive, antidiabetic and antidepressant agents during follow-up; and 3) the Charlson comorbidity index score [23].”
BackgroundPhotosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma
Su, K. A., Habel, L. A., Achacoso, N. S., FRIEDMAN, G. D., & Asgari, M. M. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16713 · Cited by 45
Health Beliefs and Medication Adherence in Omanis With Hypertension
Al‐Noumani, H., Wu, J. R., Barksdale, D. J., Knafl, G. J., Al-Khasawneh, E. M., & Sherwood, G. D. (2018) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000511 · Cited by 43
Davis, K. L., Meyers, J., Zhao, Z., McCollam, P. L., & Murakami, M. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.28852 · Cited by 44
Estimating the Cost of Serious Injurious Falls in a Canadian Acute Care Hospital
Zecevic, A., Chesworth, B. M., Zaric, G. S., Huang, Q., Salmon, A., McAuslan, D., Welch, R., & Brunton, D. (2012) · Canadian Journal on Aging / La Revue canadienne du vieillissement · doi:10.1017/s0714980812000037 · Cited by 42
Protective effects of antihypertensive treatment in patients aged 85 years or older
Corrao, G., Rea, F., Compagnoni, M. M., Merlino, L. G., & Mancia, G. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001323 · Cited by 44
A case-mix classification system for explaining healthcare costs using administrative data in Italy
Corti, M. C., Avossa, F., Schievano, E., Gallina, P., Ferroni, E., Alba, N., Dotto, M., Basso, C., Netti, S. T., Fedeli, U., et al. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.02.035 · Cited by 43
Meister, F., Lurje, G., Verhoeven, S., Wiltberger, G. J., Heij, L. R., Liu, W., Jiang, D., Bruners, P., Lang, S. A., Ulmer, T. F., et al. (2022) · Cancers · doi:10.3390/cancers14030720 · Cited by 43
“liver disease), Charlson Comorbidity Index (CCi) [31]; Clavien–Dindo classification (CD) and the Comprehensive Complication Index (CCI) [32,33], procedural costs [34], calcula-”
BackgroundMethodYoung, J. Q., Kline‐Simon, A. H., Mordecai, D. J., & Weisner, C. M. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.12.005 · Cited by 42
“The Charlson Comorbidity Index is a weighted score of 17 conditions which predicts the risk of 10-year mortality for patients with a range of these diagnosis-based comorbid conditions [26,27].”
BackgroundChen, S., Choi, C., Li, Q., Yeh, W., Lee, Y., Kao, A. H., & Liang, M. H. (2015) · Arthritis Care & Research · doi:10.1002/acr.22574 · Cited by 42
“The Charlson Comorbidity Index (CCI), a weighted measure derived from ICD-9-CM diagnosis codes to predict mortality, was calculated to predict costs (19).”
MethodPark, H., Rascati, K. L., Lawson, K. A., Barner, J. C., Richards, K. M., & Malone, D. C. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.8.862 · Cited by 42
Hidalgo-Tenorio, C., Sadyrbaeva-Dolgova, S., Enríquez‐Gómez, A., Muñóz, P., Plata, A., Miró, J. M., de Alarcón, A., Martínez‐Marcos, F. J., Loeches, B., Escrihuela-Vidal, F., et al. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106918 · Cited by 41
The impact of electronic health records on care of heart failure patients in the emergency room
Connelly, D. P., Park, Y., Du, J., Theera-Ampornpunt, N., Gordon, B. D., Bershow, B. A., Gensinger, R. A., Shrift, M., Routhe, D. T., & Speedie, S. M. (2011) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000271 · Cited by 41
Constantinou, P., Tuppin, P., Fagot‐Campagna, A., Gastaldi‐Ménager, C., Schellevis, F., & Pelletier‐Fleury, N. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.07.003 · Cited by 49
Igarashi, H., Ueda, K., Jung, S.-E., Cai, Z., Chen, Y., & Nakamura, T. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038987 · Cited by 38
Sabatini, S., Woods, B. T., Ukoumunne, O. C., Ballard, C. G., Collins, R., & Clare, L. (2021) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2021.1923634 · Cited by 44
“Questions were mapped onto the Charlson Comorbidity Index (Charlson et al., 2008, 1987); in line with the Charlson Comorbidity Index, a summary score (0–22) was created by scoring each positive answer as one, except for cancer which was scored two or three depending on whether it was past or…”
MethodTsiachristas, A., Cramm, J. M., Nieboer, A. P., & Mölken, M. R. (2014) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-12-17 · Cited by 40
“The mean multi-morbidity among the respondents measured by the Charlson comorbidity index [18] was 1.”
MethodKim, K.-S., Son, H.-G., Hong, N.-S., & Lee, D. (2012) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.2012.45.3.196 · Cited by 40
“[16], to classify comorbid conditions that might alter the risk of mortality, was found to be a valid method of estimating risk of death from comorbid disease in longitudinal studies [17,18].”
MethodKabadi, S., Goyal, R., Nagar, S. P., Kaye, J. A., & Davis, K. L. (2019) · Cancer Medicine · doi:10.1002/cam4.2268 · Cited by 40
Huguet, N., Larson, A. E., Angier, H. E., Marino, M., Green, B. B., Moreno, L., & DeVoe, J. E. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab069 · Cited by 40
Vimont, A., Leleu, H., & Durand-zaleski, I. (2021) · European Journal of Health Economics · doi:10.1007/s10198-021-01363-4 · Cited by 36
Loyola, W. S., Camillo, C. A., Torres, C. V., & Probst, V. S. (2018) · Geriatrics & Gerontology International · doi:10.1111/ggi.13167 · Cited by 39
Costs of herpes zoster complications in older adults: A cohort study of US claims database
Meyers, J., Candrilli, S. D., Rausch, D. A., Yan, S., Patterson, B. J., & Levin, M. J. (2019) · Vaccine · doi:10.1016/j.vaccine.2018.11.079 · Cited by 39
“The CCI score includes 20 categories of comorbidities as defined by ICD-9-CM diagnosis and procedure codes, with associated weights corresponding to the severity of the comorbid condition of interest [12,13].”
MethodGuerriere, D. N., Husain, A. F., Marshall, D., Zagorski, B., Seow, H. Y., Brazil, K., Kennedy, J., McLernon, R., Burns, S., & Coyte, P. C. (2015) · Journal of Palliative Care · doi:10.1177/082585971503100203 · Cited by 38
Iturralde, E., Slama, N. E., Kline‐Simon, A. H., Young‐Wolff, K. C., Mordecai, D., & Sterling, S. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.11.002 · Cited by 41
Peterson, J. C., Paget, S. A., Lachs, M. S., Reid, M. C., & Charlson, M. E. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200473 · Cited by 39
Self-citationOhno, S., Chen, Y., Sakamaki, H., Matsumaru, N., Yoshino, M., & Tsukamoto, K. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.1880801 · Cited by 38
Röttger, J., Blümel, M., Köppen, J., & Busse, R. (2016) · Health Policy · doi:10.1016/j.healthpol.2016.01.004 · Cited by 44
Buja, A., Solinas, G., Visca, M., Federico, B., Gini, R., Baldo, V., Francesconi, P., Sartor, G., Bellentani, M. D., & Damiani, G. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13020238 · Cited by 39
“The Charlson Index (CI) [16] was calculated by applying Charlson’s algorithm to the hospital discharge diagnoses recorded for a patient in the previous three years.”
MethodReal-world characteristics of elderly patients with overactive bladder in the United States
Ganz, M. L., Liu, J., Zou, K. H., Bhagnani, T., & Luo, X. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1226167 · Cited by 38
Mi, R. Z., Hollander, M. M., Jones, C. M. C., DuGoff, E. H., Caprio, T. V., Cushman, J. T., Kind, A., Lohmeier, M., & Shah, M. N. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0792-5 · Cited by 39
“Covariates Medical history, including Charlson Comorbidity Index [41] Baseline Patient survey”
MethodTai, H., Zhu, Z., Mei, H., Sun, W., & Zhang, W. (2020) · Mediators of Inflammation · doi:10.1155/2020/7280708 · Cited by 38
“In order to assess the disease severity, American Society of Anesthesiologists (ASA) physical status, Acute Physiology and Chronic Health Evaluation (APACHE) II score, Sepsis-related Organ Failure Assessment (SOFA) score [8], Simplified Acute Physiology Score (SAPS) III [9], and modified Charlson comorbidity index (MC…”
MethodSalanitro, A. H., Hovater, M. K., Hearld, K. R., Roth, D. L., Sawyer, P., Locher, J. L., Bodner, E. V., Brown, C. J., Allman, R. M., & Ritchie, C. S. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04121.x · Cited by 38
Tseng, C., Tu, C., Chen, C., Wang, Y., Chen, W., Fu, P., Chen, C., Lai, C., Kuo, L., Ku, S., et al. (2021) · Nutrients · doi:10.3390/nu14010198 · Cited by 37
Long-term use of statins reduces the risk of hospitalization for dementia
Corrao, G., Ibrahim, B., Nicotra, F., Zambon, A., Merlino, L. G., Pasini, T. S., Catapano, A. L., & Mancia, G. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.009 · Cited by 37
“In addition, the Charlson comorbidity score was calculated [16] using the diagnostic information available from inpatient charts in the three years prior the index date and during the first year of follow-up.”
MethodCai, J. X., Wang, Y., Başer, O., Xie, L., & Chow, W. S. (2016) · Journal of Medical Economics · doi:10.1080/13696998.2016.1208208 · Cited by 37
“Only 1 filled, n (%) 144 (9) 104 (8) 112 (13)* 55 (13)* 579 (17)* 78 (15)* 116 (17)* 317 (16)* 84 (31)* 168 (19)*”
Andreassen, A. E. S., Jacobsen, C. M., de Blasio, B. F., White, R. A., Kristiansen, I. S., & Elstrøm, P. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-017-0232-x · Cited by 37
Shcherbakova, N., Tereso, G. J., Spain, J., & Roose, R. J. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028017751913 · Cited by 37
Cartmell, K. B., Dismuke, C. E., Dooley, M. J., Mueller, M., Nahhas, G. J., Warren, G. W., Fallis, P., & Cummings, K. M. (2018) · Medical Care · doi:10.1097/mlr.0000000000000979 · Cited by 37
Carleton, N. M., Zou, J., Fang, Y., Koscumb, S., Shah, O. S., Chen, F., Beriwal, S., Diego, E. J. B., Brufsky, A., Oesterreich, S., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.6322 · Cited by 40
Prevalencia y factores asociados de fragilidad en adultos mayores de 70 años en la comunidad
Menéndez-González, L., Izaguirre-Riesgo, A., Tranche-Iparraguirre, S., Montero-Rodríguez, Á., & Orts‐Cortés, M. I. (2021) · Atención Primaria · doi:10.1016/j.aprim.2021.102128 · Cited by 37
“Alterada 5 (4,5) 1,5-10,1 48 (26,2) 20-33,2 87 (77) 68,1-84,4 < 0,001 17,9 (7,1-45,3)*”
Influentialde Lima, J. D., Teixeira, I. A., Silva, F. D. O., & Deslandes, A. C. (2020) · IBRO Reports · doi:10.1016/j.ibror.2020.07.008 · Cited by 35
Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes
Rettig, S. M., Wood, Y., & Hirsch, J. D. (2013) · Journal of the American Pharmacists Association · doi:10.1331/japha.2013.13003 · Cited by 36
Chi, F. W., Parthasarathy, S., Palzes, V. A., Kline‐Simon, A. H., Metz, V. E., Weisner, C. M., Satre, D. D., Campbell, C. I., Elson, J., Ross, T. B., et al. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109458 · Cited by 38
Candrilli, S. D., Meyers, J., Boye, K. S., & Bae, J. P. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.009 · Cited by 35
Sterling, S., Parthasarathy, S., Jones, A., Weisner, C., Metz, V., Hartman, L., Saba, K., & Kline-Simon, A. H. (2022) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2021.11.033 · Cited by 33
“The Charlson comorbidity score was calculated based on diagnosis codes made in the year prior to index, and used to account for medical comorbidity and disease severity where a higher score is associated with worse outcomes (ranging from 0-6) [40].”
MethodDai, D., Samiian, A., Fernandes, J., & Coetzer, H. (2022) · Journal of health economics and outcomes research · doi:10.36469/001c.37307 · Cited by 34
Karve, S. J., Lorenzo, M. J., Liepa, A. M., Hess, L. M., Kaye, J. A., & Calingaert, B. (2015) · Journal of the Korean Gastric Cancer Association · doi:10.5230/jgc.2015.15.2.87 · Cited by 34
“The Charlson Comorbidity Index (excluding gastric cancer) was calculated to obtain a measure of the patients’ overall comorbidity burden during the 6-month period preceding the gastric cancer index date.(14) The presence of ascites during the follow-up period was also recorded.”
Gundlapalli, A. V., Redd, A. M., Bolton, D., Vanneman, M. E., Carter, M. E., Johnson, E. E., Samore, M. H., Fargo, J. D., & O'Toole, T. P. (2017) · Medical Care · doi:10.1097/mlr.0000000000000770 · Cited by 34
Huynh, C., Puyraimond‐Zemmour, D., Maillefert, J.-F., Conaghan, P. G., Davis, A. M., Günther, K.-P., HAWKER, G. A., Hochberg, M. C., Kloppenburg, M., Lim, K., et al. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.06.013 · Cited by 34
Shang, J., Wang, J., Adams, V., & Ma, C. (2020) · Research in Nursing & Health · doi:10.1002/nur.22053 · Cited by 35
“The Charlson comorbidity index, originating in the inpatient setting, is a weighted index of selected comorbid diseases (Charlson et al., 2008; Deyo, Cherkin, & Ciol, 1992), which has been used in the HHC setting previously (Wang, Kearney, Jia, & Shang, 2016).”
MethodJędrzejczyk, M., Foryś, W. J., Czapla, M., & Uchmanowicz, I. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19063461 · Cited by 34
“The maximum number of points is 4 for age equal to or greater than 80 [19,20].”
BackgroundBowers, C. A., Varela, S., Naftchi, A., Kazim, S. F., Hall, D. E., Ng, C., Rawanduzy, C. A., Spirollari, E., Vazquez, S. M., Das, A., et al. (2023) · Journal of Neurosurgery Spine · doi:10.3171/2023.5.spine221020 · Cited by 33
Breast cancer treatment in women over the age of 80: A tailored approach
Glaser, R. L., Marinopoulos, S. S., & Dimitrakakis, C. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.01.014 · Cited by 33
“, Charlson comorbidity index) takes into account the number and seriousness of comorbid conditions, and their effect on mortality [4].”
BackgroundSelf-citationCairns, M., Ostrum, R. F., & Clement, R. C. (2018) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.17.00327 · Cited by 33
Drinking Patterns of Older Adults with Chronic Medical Conditions
Ryan, M., Merrick, E. L., Hodgkin, D., Horgan, C. M., Garnick, D. W., Panas, L., Ritter, G. A., Blow, F. C., & Saitz, R. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2409-1 · Cited by 33
Rascati, K. L., Richards, K. M., Ott, C. A., Goddard, A. W., Stafkey-Mailey, D., Alvir, J. M., Sanders, K. N., & Mychaskiw, M. A. (2011) · Psychiatric Services · doi:10.1176/ps.62.9.pss6209_1032 · Cited by 34
Martinson, B. C., Sherwood, N. E., Crain, A. L., Hayes, M. G., King, A. C., Pronk, N., & O’Connor, P. J. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.04.002 · Cited by 33
“…Charlson comorbidity score N3, a standard index of comorbidity calculated using prior year diagnoses of a broad range of serious medical conditions (Charlson et al., 2008, 1994; Deyo et al., 1992; Rush et al., 2000), or had diagnoses of coronary heart disease (CHD), congestive heart failure (CHF),…”
MethodYoon, S., Kim, E. J., Seo, H., & Oh, I. (2015) · BioMed Research International · doi:10.1155/2015/259341 · Cited by 32
“Previous studies have reported that higherCCI in patients with renal failure or head/neck cancer had increased medical costs and that CCI = 2 patients’ medical costs had the highest rate of increase [20, 21].”
ResultVariation in Care for Patients with Irritable Bowel Syndrome in the United States
Lacy, B. E., Patel, H., Guérin, A., Dea, K., Scopel, J., Alaghband, R., Wu, E. Q., & Mody, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154258 · Cited by 32
“Results were reported as adjusted incidence rate ratios (IRRs) with 95% confidence intervals (CIs) [32].”
BackgroundKasthurirathne, S. N., Biondich, P., Grannis, S. J., Purkayastha, S., Vest, J. R., & Jones, J. (2019) · Journal of Medical Internet Research · doi:10.2196/13809 · Cited by 34
“We selected 3 high-risk patient groups: group A: patients with a past diagnosis of depression, group B: patients with a Charlson Comorbidity Index [32] of ≥ 1, and group C: patients with a Charlson Comorbidity Index of ≥ 2.”
Kato, T., Baba, K., Guo, W., Chen, Y., & Nosaka, T. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.104 · Cited by 32
Angier, H. E., Ezekiel-Herrera, D., Marino, M., Hoopes, M. J., Jacobs, E. A., DeVoe, J. E., & Huguet, N. (2019) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2019.0011 · Cited by 33
Vest, J. R., Gamm, L. D., Ohsfeldt, R. L., Zhao, H., & Jasperson, J. (2011) · Journal of Medical Systems · doi:10.1007/s10916-011-9712-3 · Cited by 31
“In terms of clinical indicators, we measured patient complexity in terms of the adapted Charlson comorbidity index score (excluding use of warfarin) [25].”
A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras
Brown, J. D., Shewale, A. R., Dherange, P., & Talbert, J. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0369-y · Cited by 31
Campbell, C. I., Bahorik, A. L., Kline‐Simon, A. H., & Satre, D. D. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.04.017 · Cited by 30
“Income =median neighborhood income. a χ2 test or independent samples t-test (two-tailed). b Charlson Comorbidity Index= higher mean scores indicate greater medical disease burden (Charlson et al., 2008).”
BackgroundMethodInfluentialBahorik, A. L., Satre, D. D., Kline‐Simon, A. H., Weisner, C. M., Young‐Wolff, K. C., & Campbell, C. I. (2017) · Substance Abuse · doi:10.1080/08897077.2017.1356789 · Cited by 31
Newman, J. M., Sodhi, N., Khlopas, A., Piuzzi, N. S., Yakubek, G. A., Sultan, A. A., Klika, A. K., Higuera, C. A., & Mont, M. A. (2019) · Hip International · doi:10.1177/1120700019862977 · Cited by 31
Hidalgo-Tenorio, C., Gálvez-Acebal, J., Martínez‐Marcos, F. J., Plata, A., Lima, J. D. L. T., López-Cortés, L. E., Noureddine, M., Reguera, J. M., García, D. V., García, M. V., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4895-1 · Cited by 31
Impact of Methicillin Resistant Staphylococcus aureus Contact Isolation Units on Medical Care
Masse, V., Valiquette, L., Boukhoudmi, S., Bonenfant, F., Talab, Y., Carvalho, J.-C., Alarie, I., Carrier, N., & Farand, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057057 · Cited by 31
“Charlson comorbidity scores were used to quantify the overall burden of comorbidities [7].”
MethodNewman, J. M., Sodhi, N., Wilhelm, A. B., Khlopas, A., Klika, A. K., Naziri, Q., Kryzak, T. J., Higuera, C. A., & Mont, M. A. (2018) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-018-4970-y · Cited by 30
Grieco, M., Cassini, D., Spoletini, D., Soligo, E., Grattarola, E., Baldazzi, G., Testa, S., & Carlini, M. (2019) · Surgical Laparoscopy Endoscopy & Percutaneous Techniques · doi:10.1097/sle.0000000000000653 · Cited by 30
“001† Time to autonomous mobilization (median±SD, range) (d) 2± 1 (1-6) 2± 1.”
Age-Related Frailty: A Clinical Model for Geroscience?
Takeda, C., Angioni, D., Setphan, E., Macaron, T., Barreto, P. D. S., Sourdet, S., Sierra, F., & Vellas, B. J. (2020) · The journal of nutrition health & aging · doi:10.1007/s12603-020-1491-4 · Cited by 31
“There are plenty of tools being used for measuring frailty (4, 5, 52) and multimorbidity (53-55), and these tools are probably not selecting the same profile of individuals.”
Sarmiento-Monroy, J. C., Espinosa, G., Londoño, M., Meira, F. S., Caballol, B., Llufriú, S., Carrasco, J. L., Moll‐Udina, A., Quintana, L. F., Giavedoni, P., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102580 · Cited by 30
“The age-adjusted Charlson comorbidity index (ACCI) was calculated for each individual [15] at the time of admission.”
MethodVoraussetzungen für ein neues Versorgungsmodell für ältere Menschen mit Multimorbidität
Thiem, U., Hinrichs, T., Mueller, C. A., Holt-Noreiks, S., Nagl, A., Bucchi, C., Trampisch, U. S., Moschny, A., Platen, P., Penner, E., et al. (2011) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-011-0246-6 · Cited by 30
Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer
Tyson, M. D., Graves, A. J., O'Neil, B. B., Barocas, D. A., Chang, S. S., Penson, D. F., & Resnick, M. J. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.2907 · Cited by 29
Association of Positive Airway Pressure Use With Acute Care Utilization and Costs
Kirsch, D. B., Yang, H., Maslow, A. L., Stolzenbach, M., & McCall, A. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7912 · Cited by 28
Li, C.-L., Lin, M.-H., Chen, P.-S., Tsai, Y.-C., Shen, L.-S., Kuo, H., & Liu, S. (2020) · International Journal of COPD · doi:10.2147/copd.s234363 · Cited by 29
Barış, V. K., İntepeler, Ş. S., & Yeğinboy, E. Y. (2016) · Clinical Nursing Research · doi:10.1177/1054773816671521 · Cited by 29
“The comorbidities of the patients in the case and control groups were calculated using the Charlson Comorbidity Index (CCI), and their effect on the hospitalization cost was analyzed (Charlson et al., 2008; Charlson, Popel, Ales, & MacKenzie, 1987).”
MethodBoland, M. R. S., Tsiachristas, A., Kruis, A. L., Chavannes, N. H., & Mölken, M. R. (2014) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2014.00002 · Cited by 28
Poitras, S., Au, K., Wood, K. S., Dervin, G. F., & Beaulé, P. E. (2018) · International Orthopaedics · doi:10.1007/s00264-018-3833-y · Cited by 28
Impact of socioeconomic status on end-of-life costs: a systematic review and meta-analysis
Yu, C. W., Alavinia, M., & Alter, D. A. (2020) · BMC Palliative Care · doi:10.1186/s12904-020-0538-y · Cited by 30
Goyal, R., Nagar, S. P., Kabadi, S., Le, H., Davis, K. L., & Kaye, J. A. (2021) · Cancer Medicine · doi:10.1002/cam4.3855 · Cited by 28
Pak, S. S., Miller, M. J., & Cheuy, V. A. (2021) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00360-8 · Cited by 28
“Previous studies have shown that CCI holds prognostic value in determining who is likely to incur higher future costs based on the assigned weight of different comorbid health conditions [34, 54].”
BackgroundQin, Z., Zhao, J., Li, J., Yang, Q., Geng, J., Liao, R., & Su, B. (2021) · Aging · doi:10.18632/aging.203480 · Cited by 28
“Comorbidity index reflected the health status of patients and was of great significance for disease management, clinical treatment and prognosis [39].”
Metadata
- Authors
- Charlson, M. E., Charlson, R. E., Peterson, J. C., Marinopoulos, S. S., Briggs, W. M., & Hollenberg, J. P.
- Affiliations
- Weill Cornell Medicine (US)
- Yale New Haven Hospital (US)
- Johns Hopkins University (US)
- Central Michigan University (US)
- Corresponding author
- Charlson, Mary E.
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 61
- Issue
- 12
- Pages
- 1234-1240
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2110548428
- Cited by
- 894
- References
- 38
- Citations by year
- 2026: 35 · 2025: 52 · 2024: 79 · 2023: 74 · 2022: 80 · 2021: 77 · 2020: 81 · 2019: 66 · 2018: 83 · 2017: 56 · 2016: 42 · 2015: 51 · 2014: 37 · 2013: 21 · 2012: 22
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- Charlson Comorbidity Index, chronic disease costs, health care costs, primary care patients, cost prediction model, hospital costs, resource utilization (health care), hypertension, depression, warfarin, skin ulcers, cellulitis, Medicare and Medicaid, elderly patients
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Chronic Disease, Epidemiologic Methods, Female, Health Resources, Health Services Research, Hospitalization, Humans, Male, Middle Aged, New York City, Primary Health Care, Prognosis, Drug Costs, Health Care Costs, Hospital Costs, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review